Bioforce Nanosciences Holdings BFNH Growth Metrics (2020-2026)

OTC BFNH
$7.41 -0.78 (-9.52%)
At close: Oct 27, 2026 · 4:00 PM EDT
Reported Financials

Bioforce Nanosciences Holdings Quarterly Growth Metrics

Periods 26 quarters
Latest Jun 2026

Bioforce Nanosciences Holdings reported asset growth of 1,439.89% for the quarter ended Jun 2026. These growth metrics cover 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Return on Assets [ROA] (QoQ)ROA (QoQ)
-5.18M1.37M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.66M
Operating Income (QoQ)Op. Inc (QoQ)
-6.63%8.00%5.59%
Operating Income Growth (1y)Op. Inc Growth (1y)
-7.29%5.01%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
6.91%-6.01%-9.70%12.56%-5.88%6.41%-13.31%12.36%0.28%-0.71%-14.34%12.52%-6.63%-0.93%-658.89%86.86%5.59%333.06%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
0.63%0.34%6.73%31.63%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
3.48%1.23%2.27%3.39%2.19%-2.34%-0.67%-91.83%-1.98%1.85%7.64%59.99%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
3.44%1.52%8.73%5.34%-7.66%4.94%1.81%1.60%7.33%0.28%-0.62%-0.45%-7.41%-7.65%-614.49%-7.29%5.01%89.04%294.40%
Net Income (QoQ)
6.91%-6.01%-9.70%12.56%-5.88%6.41%-13.31%12.36%0.28%-0.71%-14.34%12.52%-6.63%-0.93%-658.89%86.86%6.25%-3.04%13.65%333.06%
Net Income Growth (5y)
-43.60%64.16%0.63%0.48%0.65%6.73%31.63%
Net Income Growth (3y)
-78.51%90.63%3.48%1.23%2.27%3.39%2.19%-2.34%-0.67%-91.83%-1.98%2.08%-1.11%7.64%59.99%
Net Income Growth (1y)
3.44%1.52%8.73%5.34%-7.66%4.94%1.81%1.60%7.33%0.28%-0.62%-0.45%-7.41%-7.65%-614.49%-7.29%5.67%3.70%89.04%294.40%
Net Cash Flow (QoQ)NCF (QoQ)
-352.27%99.81%-200.00%33.33%200.00%-250.00%104.17%1,250.00%3,485.19%-179.86%1,773.61%-199.67%99.06%101.65%277,950.00%-208.61%
Net Cash Flow Growth (5y)NCF Growth (5y)
-16.32%32.90%-12.99%21.91%-5.92%
Net Cash Flow Growth (3y)NCF Growth (3y)
-26.05%80.03%83.40%26.00%26.12%63.73%-90.16%75.75%28.56%390.28%-473.63%
Net Cash Flow Growth (1y)NCF Growth (1y)
58.61%99.90%98.29%100.38%-200.00%104.17%184.38%2,925.00%-1,510.42%646,750.00%-47,855.56%-112.50%100.26%-57.01%53.16%
Income After Tax (QoQ)
-6.63%8.00%5.59%-122.82%
Income After Tax Growth (1y)
-7.29%5.01%11.78%-113.66%
Free Cash Flow (QoQ)FCF (QoQ)
68.68%-4.22%-264.27%70.78%-70.33%42.47%-144.45%62.50%8.42%10.50%-148.11%23.83%-15.31%3.93%-2.56%-83.33%60.13%1.80%164.90%-480.64%
Free Cash Flow Growth (5y)FCF Growth (5y)
-7.65%17.43%-6.07%-5.17%0.41%17.28%0.53%
Free Cash Flow Growth (3y)FCF Growth (3y)
2.77%16.52%25.34%2.88%14.02%18.39%21.52%-21.18%-17.94%22.70%-42.58%12.13%-5.01%32.14%-46.14%
Free Cash Flow Growth (1y)FCF Growth (1y)
-0.40%18.88%-1.84%65.26%-88.92%-4.29%30.01%10.17%51.70%24.86%23.74%-54.91%-95.05%-109.36%13.46%-108.28%27.98%26.38%146.59%3.27%
EPS (Diluted) (QoQ)
-6.01%-9.70%12.56%-5.88%6.41%-13.31%12.36%0.28%-0.71%-14.34%12.52%-6.63%-0.93%-588.88%87.36%5.59%332.91%
EPS (Diluted) Growth (3y)
-2.34%-0.67%-85.74%2.53%6.18%11.73%56.43%
EPS (Diluted) Growth (1y)
-7.66%4.94%1.81%1.60%7.33%0.28%-0.62%-0.45%-7.41%-7.65%-548.58%6.31%17.05%89.46%294.27%
EPS (Basic) (QoQ)
6.91%-6.01%-9.70%12.56%-5.88%6.41%-13.31%12.36%0.28%-0.71%-14.34%12.52%-6.63%-0.93%-588.88%87.36%5.59%332.91%
EPS (Basic) Growth (5y)
15.09%14.84%9.22%29.93%
EPS (Basic) Growth (3y)
22.30%20.49%19.59%3.39%2.19%-2.34%-0.67%-85.74%2.53%6.18%11.73%56.43%
EPS (Basic) Growth (1y)
49.62%45.15%8.73%5.34%-7.66%4.94%1.81%1.60%7.33%0.28%-0.62%-0.45%-7.41%-7.65%-548.58%6.31%17.05%89.46%294.27%
EBT (QoQ)
-6.63%8.00%5.59%-122.82%
EBT Growth (1y)
-7.29%5.01%11.78%-113.66%
EBIT (QoQ)
-6.63%8.00%5.59%-122.82%
EBIT Growth (1y)
-7.29%5.01%11.78%-113.66%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
68.68%-4.22%-264.27%70.78%-70.33%42.47%-144.45%62.50%8.42%10.50%-148.11%23.83%-15.31%3.93%-2.56%-83.33%60.13%1.80%164.90%-480.64%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-7.65%17.43%-6.07%-5.17%0.41%17.28%0.53%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
2.77%16.52%25.34%2.88%14.02%18.39%21.52%-21.18%-17.94%22.70%-42.58%12.13%-5.01%32.14%-46.14%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-0.40%18.88%-1.84%65.26%-88.92%-4.29%30.01%10.17%51.70%24.86%23.74%-54.91%-95.05%-109.36%13.46%-108.28%27.98%26.38%146.59%3.27%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
0.00%-59.33%0.00%-16.88%-91.87%-2.13%-6.54%-4.66%4.89%-7.00%0.31%4.22%145.13%-47.28%1,500.81%-93.44%-13.37%0.26%707.51%-95.16%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
-56.10%-53.10%-54.42%-54.40%-59.25%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
-75.97%-74.59%-74.18%-74.80%-70.98%-60.88%-57.34%7.51%-53.89%1.49%2.31%109.93%-22.28%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
-31.51%-72.14%-66.20%-97.25%-93.39%-93.82%-92.91%-8.53%-13.08%-6.71%1.99%138.34%35.11%2,056.09%35.68%-52.05%-8.82%-54.00%-66.08%
Assets (QoQ)
-0.11%-59.29%-0.27%-16.96%-91.87%-2.13%-6.54%-4.66%4.89%-7.00%0.31%4.22%145.13%-47.28%1,500.81%-93.44%-13.37%0.26%707.51%37,525.26%
Assets Growth (5y)
-54.40%144.37%
Assets Growth (3y)
-74.80%-71.02%-60.91%-57.39%7.48%-53.89%1.49%2.31%109.93%1,439.89%
Assets Growth (1y)
-72.04%-66.32%-97.26%-93.41%-93.83%-92.91%-8.53%-13.08%-6.71%1.99%138.34%35.11%2,056.09%35.68%-52.05%-8.82%-54.00%263,775.69%

Bioforce Nanosciences Holdings Growth Metrics API

Pull Bioforce Nanosciences Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BFNH&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY